欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6203/004
药品名称Rivaroxaban-ratiopharm 20 mg Filmtabletten
活性成分
    • RIVAROXABAN 20.0 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Rivaroxaban-ratiopharm 20 mg Filmtabletten
互认成员国 - 产品名称
    • Latvia (LV)
    • Iceland (IS)
    • Lithuania (LT)
      Rivaroxaban Teva 20 mg plėvele dengtos tabletės
    • United Kingdom (Northern Ireland) (XI)
    • Estonia (EE)
      RIVAROXABAN TEVA
    • Ireland (IE)
    • Hungary (HU)
    • Austria (AT)
      Rivaroxaban ratiopharm 20 mg Filmtabletten
    • Czechia (CZ)
      Rivaroxaban Teva
    • France (FR)
    • Romania (RO)
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Slovenia (SI)
    • Italy (IT)
    • Croatia (HR)
      Rivaroksaban Pliva 20 mg filmom obložene tablete
    • Denmark (DK)
      Rivaroxaban Teva
    • Sweden (SE)
    • Belgium (BE)
      Rivaroxaban Teva 20 mg filmomhulde tabletten
    • Norway (NO)
      Rivaroxaban Teva
    • Netherlands (NL)
    • Finland (FI)
    • Luxembourg (LU)
许可日期2020/12/02
最近更新日期2024/07/02
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase